Literature DB >> 28736340

TFOS DEWS II pathophysiology report.

Anthony J Bron1, Cintia S de Paiva2, Sunil K Chauhan3, Stefano Bonini4, Eric E Gabison5, Sandeep Jain6, Erich Knop7, Maria Markoulli8, Yoko Ogawa9, Victor Perez10, Yuichi Uchino9, Norihiko Yokoi11, Driss Zoukhri12, David A Sullivan3.   

Abstract

The TFOS DEWS II Pathophysiology Subcommittee reviewed the mechanisms involved in the initiation and perpetuation of dry eye disease. Its central mechanism is evaporative water loss leading to hyperosmolar tissue damage. Research in human disease and in animal models has shown that this, either directly or by inducing inflammation, causes a loss of both epithelial and goblet cells. The consequent decrease in surface wettability leads to early tear film breakup and amplifies hyperosmolarity via a Vicious Circle. Pain in dry eye is caused by tear hyperosmolarity, loss of lubrication, inflammatory mediators and neurosensory factors, while visual symptoms arise from tear and ocular surface irregularity. Increased friction targets damage to the lids and ocular surface, resulting in characteristic punctate epithelial keratitis, superior limbic keratoconjunctivitis, filamentary keratitis, lid parallel conjunctival folds, and lid wiper epitheliopathy. Hybrid dry eye disease, with features of both aqueous deficiency and increased evaporation, is common and efforts should be made to determine the relative contribution of each form to the total picture. To this end, practical methods are needed to measure tear evaporation in the clinic, and similarly, methods are needed to measure osmolarity at the tissue level across the ocular surface, to better determine the severity of dry eye. Areas for future research include the role of genetic mechanisms in non-Sjögren syndrome dry eye, the targeting of the terminal duct in meibomian gland disease and the influence of gaze dynamics and the closed eye state on tear stability and ocular surface inflammation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DEWS II; Dry eye disease; Dry eye workshop; Glycocalyx; Hyperosmolarity; Inflammation; Pathophysiology; TFOS; Vicious circle

Mesh:

Year:  2017        PMID: 28736340     DOI: 10.1016/j.jtos.2017.05.011

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  300 in total

1.  Suppression of Th1-Mediated Keratoconjunctivitis Sicca by Lifitegrast.

Authors:  Rodrigo Guimaraes de Souza; Zhiyuan Yu; Michael E Stern; Stephen C Pflugfelder; Cintia S de Paiva
Journal:  J Ocul Pharmacol Ther       Date:  2018-06-29       Impact factor: 2.671

2.  Dry Eye Assessment and Management (DREAM©) Study: Study design and baseline characteristics.

Authors:  Penny A Asbell; Maureen G Maguire; Ellen Peskin; Vatinee Y Bunya; Eric J Kuklinski
Journal:  Contemp Clin Trials       Date:  2018-06-06       Impact factor: 2.226

3.  The Dry Eye Assessment and Management (DREAM) extension study - A randomized clinical trial of withdrawal of supplementation with omega-3 fatty acid in patients with dry eye disease.

Authors:  Munira Hussain; Roni M Shtein; Maxwell Pistilli; Maureen G Maguire; Marko Oydanich; Penny A Asbell
Journal:  Ocul Surf       Date:  2019-08-16       Impact factor: 5.033

4.  Are BALB/c Mice Relevant Models for Understanding Sex-Related Differences in Gene Expression in the Human Meibomian Gland?

Authors:  Xiaomin Chen; Benjamin D Sullivan; Raheleh Rahimi Darabad; Shaohui Liu; Wendy R Kam; David A Sullivan
Journal:  Cornea       Date:  2019-12       Impact factor: 2.651

5.  Meibomian glands visibility assessment through a new quantitative method.

Authors:  José Vicente García-Marqués; Santiago García-Lázaro; Noelia Martínez-Albert; Alejandro Cerviño
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-06       Impact factor: 3.117

Review 6.  TFOS DEWS II Tear Film Report.

Authors:  Mark D P Willcox; Pablo Argüeso; Georgi A Georgiev; Juha M Holopainen; Gordon W Laurie; Tom J Millar; Eric B Papas; Jannick P Rolland; Tannin A Schmidt; Ulrike Stahl; Tatiana Suarez; Lakshman N Subbaraman; Omür Ö Uçakhan; Lyndon Jones
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

7.  Characterization of dry eye disease in a mouse model by optical coherence tomography and fluorescein staining.

Authors:  Alina Messner; Corinna Fischak; Martin Pfister; Kornelia Schützenberger; Fabian Garreis; Friedrich Paulsen; Hannes Stegmann; Valentin Aranha Dos Santos; Gerhard Garhöfer; Leopold Schmetterer; René M Werkmeister
Journal:  Biomed Opt Express       Date:  2019-08-28       Impact factor: 3.732

Review 8.  A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain.

Authors:  Harrison Dermer; Daniella Lent-Schochet; Despoina Theotoka; Christian Paba; Abdullah A Cheema; Ryan S Kim; Anat Galor
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

9.  Comparative Evaluation of Clinical Methods of Tear Film Stability Assessment: A Randomized Crossover Trial.

Authors:  Michael T M Wang; Jennifer P Craig
Journal:  JAMA Ophthalmol       Date:  2018-03-01       Impact factor: 7.389

10.  Aged Mice Exhibit Severe Exacerbations of Dry Eye Disease with an Amplified Memory Th17 Cell Response.

Authors:  William Foulsham; Sharad K Mittal; Yukako Taketani; Yihe Chen; Takeshi Nakao; Sunil K Chauhan; Reza Dana
Journal:  Am J Pathol       Date:  2020-04-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.